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To	tackle	the	opioid	crisis,	the	US	should	look	to
Switzerland’s	successes	with	substitution	therapy
The	US	is	facing	an	opioid	crisis	at	a	colossal	scale.	But	Switzerland	has	been	there	before.	Christian
Schneider	looks	back	to	the	policy	innovations	introduced	to	tackle	the	European	nation’s	opioid	crisis
in	the	1990s.	By	implementing	substitution	therapy,	heroin-assisted	treatment	and	harm	reduction
measures,	he	writes,	the	US	may	be	able	to	begin	to	get	a	grip	not	only	on	the	health	consequences	of
this	crisis	but	also	on	the	illegal	supply	of	opioids.	
American	cities	are	increasingly	considering	measures	to	address	the	extraordinary	costs	of	the	current	opioid	crisis
in	the	US	that	go	beyond	what	is	to	be	found	in	the	traditional	drug	policy	toolbox.	Plans	to	allow	safe	injection
facilities	in	some	cities	are	likely	to	be	the	starting	point	for	more	drug	policy	innovation	at	the	local	level.	While	the
current	American	opioid	crisis	is	unique	in	many	ways	it	might	be	worth	drawing	on	some	of	the	overlooked	lessons
and	policy	innovations	that	were	used	to	tackle	Switzerland’s	1990s	heroin	epidemic.
At	the	beginning	of	the	1990s,	Switzerland	was	a	paradise	for	heroin	traffickers.	It	is	estimated	that	the	incidence	of
heroin	use	peaked	in	1990	at	0.73	per	1000	inhabitants	–higher	than	in	other	European	countries	for	which
comparable	figures	exist.	Zurich,	Switzerland’s	largest	city	with	350,000	inhabitants	at	the	time	had	between	6,000
and	8,000	problematic	heroin	users	–	or	1.7	to	2.2	percent	of	its	population.	Purity	of	and	prices	for	street	heroin
were	high	and	availability	was	nearly	unrestricted.	In	every	major	Swiss	city	areas	existed	where	drug	dealing	and
consumption	were	virtually	tolerated	by	authorities.	According	to	interviews	with	consumers	and	police	informants,
heroin	trafficking	in	Switzerland	meant	high	profits	for	organized	crime	groups.	Almost	thirty	years	later,	the	Swiss
heroin	market	looks	very	different.	Infamous	open-air	drug	markets	such	as	Zurich’s	Needle	Park	are	long	gone.
Prices	and	purity	are	low	and,	according	to	a	recent	study,	heroin	trafficking	seems	not	to	be	a	particularly	lucrative
business	anymore.	Today,	heroin	is	almost	a	niche	market	in	Switzerland.
The	Swiss	heroin	market	did	not	transform	gradually	over	the	following	three	decades.	Declining	numbers	of	heroin
users	might	have	played	a	role	in	some	of	the	changes.	But	price	and	arrest	data	as	well	as	key	informant	interviews
suggest	that	the	market	shifted	within	a	few	years	starting	around	the	mid-1990s	and	has	remained	largely	stable
since.	It	seems	likely	that	the	reforms	of	Swiss	drug	policy	taking	place	from	1990	onwards	–	which	included
expanding	access	to	substitution	therapy,	heroin-assisted	treatment	and	harm	reduction	measures	–	have	played	an
important	role	in	transforming	the	heroin	market	in	Switzerland.	Measures	to	lower	the	threshold	for	substitution
therapy	included	the	prescription	of	substitution	products	by	general	practitioners,	take-home	doses	for	several	days
or	more	for	participants	with	stable	consumption	patterns,	no	requirement	of	abstinence	from	street	heroin	or	other
illicit	drugs,	no	compulsory	drug-testing	for	participants	and	open-ended	therapy	without	explicit	abstinence-oriented
therapy	goals.
By	offering	opioid	substitution	therapy	almost	unconditionally	to	virtually	anyone	willing	to	change	their	consumption
from	heroin	to	another	product,	the	health	care	system	became	a	viable	competitor	among	those	supplying	people
addicted	to	opioids	in	Switzerland.	Prescribed	in	a	way	tailored	to	fit	the	needs	of	consumers,	opioid	substitution
therapy	not	only	offered	a	much	safer	and	much	cheaper	substitute,	but	also	ensured	availability	and	access	to
products	in	way	that	street	dealers	could	never	match.	Within	a	few	years	of	its	introduction,	around	18,000	people
had	decided	to	take	this	offer	and	begin	opioid	substitution	therapy.	This	number	has	remained	stable,	suggesting
that	many	of	the	early	entrants	have	managed	to	stay	in	therapy	for	a	long	time	and	–	considering	mortality	rates	–
that	those	who	do	start	consuming	heroin	enter	substitution	therapy	some	point	of	their	addiction.	To	be	sure,	many,
if	not	most,	participants	in	opioid	substitution	therapy	in	Switzerland	still	also	consume	street	heroin	and	supply
themselves	from	illicit	markets	to	do	so.	But	they	likely	do	so	much	less	often	compared	to	when	no	substitution
program	would	exist.
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At	the	time	and,	indeed	until	today,	the	exact	mechanisms	of	the	interaction	between	the	illegal	heroin	market	and
the	legal,	state-sponsored	market	for	opioid	substitution	products	remained	underexplored.	It	is	more	than	plausible
to	assume	that	low-threshold	substitution	therapy	deprived	the	illicit	market	for	heroin	of	millions	of	Swiss	Francs	in
turnover	each	day,	making	heroin	trafficking	much	less	lucrative	than	it	could	be	if	substitution	treatment	did	not	exist
or	would	only	be	available	to	a	smaller	group	of	consumers.	Further,	it	is	plausible,	that	the	adjustments	in	price,
purity	and	organization	of	supply	observed	on	the	Swiss	heroin	market	in	the	past	decades	were	at	least	partially
caused	by	the	presence	of	low-threshold	opioid	substitution	therapy.	Street	heroin,	injected	or	inhaled,	and	orally
consumed,	pharmaceutical	methadone,	buprenorphine	or	morphine	are	not	perfect	substitutes	and	consumers	might
have	a	desire	to	consume	one	or	the	other	depending	on	set	and	setting.	However,	for	many	Swiss	consumers	their
main	opioid	of	choice	has	become	methadone	or	another	substitution	product.
Hence,	the	case	can	be	made	that	the	major	transformation	Switzerland’s	markets	for	opioids	have	experienced
might	not	have	been	from	a	highly	dynamic,	lucrative	illicit	market	to	a	stable	one,	but	from	a	market	dominated	by
illicit	entrepreneurs	offering	one	product	to	one	dominated	by	a	state-sponsored	alternative.	Low-threshold	opioid
substitution	therapy	was	not	primarily	introduced	to	change	the	economics	of	the	Swiss	heroin	market.	Opioid
substitution	therapy	was	a	public	health	intervention,	offering	heroin	consumers	alternatives	to	high-risk	consuming
behaviors.	Its	impact	on	the	Swiss	market	was	most	likely	an	unintended	but	welcome	consequence	of	policy
change.	The	state	entered	and	shaped	the	illicit	market	by	allowing	low-threshold,	nearly	unconditional	and	almost
free	access	to	a	viable	substitute	to	a	product	it	(and	society	more	broadly)	deemed	dangerous	and	damaging.
In	any	other	market,	state	intervention	at	this	scale	should	be	considered	problematic.	In	the	heroin	market,	however,
such	an	intervention	might	not	only	be	justifiable	but	also	efficient.	Obviously,	opioid	substitution	treatment	is	costly
and,	through	the	Swiss	health	insurance	system,	made	the	majority	of	society	pay	for	the	addiction	of	a	few	for
almost	three	decades	now.	But	it	is	very	likely	that	the	societal	costs	of	the	existence	of	a	highly	lucrative	heroin
market	with	several	trafficking	groups	competing	for	market	shares	and	police	forces	trying	to	keep	them	in	check
would	be	even	more	expensive.
No	matter	what	measures	US	cities	will	take	to	rein	in	the	current	opioid	crisis,	the	Swiss	experience	holds	three
lessons	for	them.	The	first	is	that	policies	can	have	unintended	consequence.	Measures	to	improve	the	health	of
drug	consumers	can	also	have	an	impact	on	supply.	Second,	what	might	look	like	weakness	on	the	side	of	policy
makers	at	one	point	in	time–	in	the	Swiss	case	the	dismissal	of	abstinence-based	treatment	in	favor	of	long-term
opioid	substitution	treatment	–	can	become	seen	as	strong	state	intervention	later	on.	Third,	before	starting	any
policy	experiment,	finding	measures	to	accurately	understand	the	market	is	essential.	If	the	Swiss	had	done	so	thirty
years	ago,	they	would	be	in	much	better	position	today	to	understand	what	large-scale,	low-threshold	opioid
substitution	treatment	had	done	to	Switzerland’s	heroin	market.
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